Nathaniel Calloway

Insider Reports History

Location
Lakeway, TX
Signature
/s/ Daniel George, as attorney-in-fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Nathaniel Calloway:

Company Role Class Num Shares Value Price $ Report Date Ownership
LIFECORE BIOMEDICAL, INC. \DE\ Director Common Stock 58,069 $406,483 $7.00 08 Jul 2024 Direct
LIFECORE BIOMEDICAL, INC. \DE\ Director Restricted Stock Unit 0 $0 $7.00 01 Feb 2024 Direct
Anebulo Pharmaceuticals, Inc. Director Stock Option (right to buy) 3,309 04 Apr 2025 Direct

Insider Reports Filed by Nathaniel Calloway

Symbol Company Period Transactions Value $ Form Type Role Filing Time
ANEB Anebulo Pharmaceuticals, Inc. 04 Apr 2025 2 $0 4 Director 07 Apr 2025, 21:41
LFCR LIFECORE BIOMEDICAL, INC. \DE\ 08 Jul 2024 1 $0 4 Director 10 Jul 2024, 19:52
ANEB Anebulo Pharmaceuticals, Inc. 13 Jun 2024 2 $0 4 Director 17 Jun 2024, 16:23
LFCR LIFECORE BIOMEDICAL, INC. \DE\ 01 Feb 2024 2 $0 4 Director 02 Feb 2024, 18:41
LFCR LIFECORE BIOMEDICAL, INC. \DE\ 09 Jan 2024 2 $0 4 Director 10 Jan 2024, 19:14
LFCR LIFECORE BIOMEDICAL, INC. \DE\ 01 Jun 2023 1 $0 4 Director 05 Jun 2023, 15:19
LFCR LIFECORE BIOMEDICAL, INC. \DE\ 01 Feb 2023 1 $0 4 Director 02 Feb 2023, 16:30
LFCR LIFECORE BIOMEDICAL, INC. \DE\ 09 Jan 2023 1 $0 4 Director 11 Jan 2023, 15:21
LFCR LIFECORE BIOMEDICAL, INC. \DE\ 09 Jan 2023 0 $0 3 Director 11 Jan 2023, 15:08
ANEB Anebulo Pharmaceuticals, Inc. 01 Nov 2022 1 $0 4 Director 02 Nov 2022, 16:31
ANEB Anebulo Pharmaceuticals, Inc. 28 Oct 2022 0 $0 3 Director 02 Nov 2022, 16:26